With Microsoft set to report earnings, investors are keenly watching updates on AI-related spending, especially growth within Azure and Copilot, as well as broader financials. A significant focus will be on capital expenditures (Capex) for generative AI initiatives, expected to rise from $9.92 billion a year ago to an estimated $14.74 billion in this recent quarter. Beyond revenue and earnings, the market is waiting to see how these hefty investments are shaping the company’s growth trajectory.
Technically,
MSFT continues to test the lower bound of its trend channel—a level that may weaken with repeated retests. The stock’s reaction to earnings will reveal if this support can hold. The formation suggests a potential head and shoulders pattern, particularly if
MSFT dips below the neckline support at $388 with declining volume.
For now, we’re maintaining our cautious outlook. If Microsoft fails to hold its key support levels, it may confirm the bearish trend we’ve been observing. As always, we’ll provide updates if any significant developments occur after the earnings report.
Technically,
For now, we’re maintaining our cautious outlook. If Microsoft fails to hold its key support levels, it may confirm the bearish trend we’ve been observing. As always, we’ll provide updates if any significant developments occur after the earnings report.
Exclusive Trading & Investing Group for Crypto & Stocks! 💎📈
Daily Stocks & Crypto Analysis | Daily Bitcoin ETF Updates | Trading Challenges & more
Join us:👇
🔗 wavemarketcapital.com/
Daily Stocks & Crypto Analysis | Daily Bitcoin ETF Updates | Trading Challenges & more
Join us:👇
🔗 wavemarketcapital.com/
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
Exclusive Trading & Investing Group for Crypto & Stocks! 💎📈
Daily Stocks & Crypto Analysis | Daily Bitcoin ETF Updates | Trading Challenges & more
Join us:👇
🔗 wavemarketcapital.com/
Daily Stocks & Crypto Analysis | Daily Bitcoin ETF Updates | Trading Challenges & more
Join us:👇
🔗 wavemarketcapital.com/
相關出版品
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。